DREADD
Designer receptors exclusively activated by designer drugs (DREADDs) are genetically engineered GPCRs that are activated by physiologically inert synthetic small molecules (designer drugs) but not their endogenous ligand. Read our DREADDs mini-review or for practical advice on using these ligands in the lab see Stability of Water-Soluble DREADD Ligands in Solution: A Technical Review and Clozapine N-Oxide (freebase) - a technical review on stability, solubility and use in the lab).
- Description:
Fluorescent M3 muscarinic receptor antagonist
![CA200887 CellAura fluorescent M<sub>3</sub> antagonist [pirenzepine]](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR4nGP6zwAAAgcBApocMXEAAAAASUVORK5CYII=)
- Description:
Fluorescent 5-HT2A receptor antagonist
-
Caffeine (HB2846)
Description:Non-selective, competitive adenosine receptor antagonist / PDE inhibitor
-
-
(S)-4-Carboxyphenylglycine (HB0049)
Description:Competitive, selective group 1 mGlu antagonist
Purity:>99%
-
-
-
CGP 54626 hydrochloride (HB0959)
Description:Potent, selective GABAB receptor antagonist
Purity:>98%
-
CGP 55845 hydrochloride (HB0960)
Description:Potent, selective GABAB receptor antagonist
Purity:>98%
-
CNQX disodium salt (HB0205)
Description:Potent, competitive AMPA / kainate receptor antagonist. Disodium salt.
Purity:>98%
![CA200887 CellAura fluorescent M<sub>3</sub> antagonist [pirenzepine]](https://hellobio.com/media/catalog/product/cache/7630ee9852b6c22c7de1165054afc779/h/b/hb7827-ca200887-image1_1.png)
